L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités

Archive

✕

24 février 2019, 14:09

61

Scientists: HIV medication will help people recovering from a stroke

Scientists: HIV medication will help people recovering from a stroke

The most serious problem associated with the rehabilitation of people after a stroke remains the loss of part of their functions by the brain. As numerous studies have shown, so far none of the tools directly affected the restoration of lost neural connections. However, ...

23 février 2019, 13:55

72

Cancer immunotherapy effectively fights HIV reservoirs

Cancer immunotherapy effectively fights HIV reservoirs

A team of specialists from the University of Montreal Hospital Research Center (CRCHUM) showed that cancer immunotherapy can reduce the HIV level in the body PLHIV if the latter are taking triple therapy. Scientists have determined how this treatment method can detect the ...

22 février 2019, 13:44

76

Only 40% of Americans do not quit PrEP for two years

Only 40% of Americans do not quit PrEP for two years

According to Walgreens, the largest pharmacy network in the United States, only two out of five people continue to receive pre-exposure prophylaxis HIV (PrEP) two years after the start. The analysis was published this week in the AIDS Society.

21 février 2019, 15:18

223

HIV prevention and effective care reduces infection among transgender women

HIV prevention and effective care reduces infection among transgender women

Программы профилактики ВИЧ-инфекции среди трансгендерных женщин позволяют сократить уровень распространения вируса, следует из результатов анализа, опубликованного в начале февраля в журнале Sexually Transmitted Diseases. Однако, по словам специалистов, для повышения эффективности ...

20 février 2019, 15:09

229

New look at widely neutralizing antibodies can improve HIV vaccine design

New look at widely neutralizing antibodies can improve HIV vaccine design

A new study conducted by specialists at Duke University Medical Center (USA), drew attention to the importance of studying the previously unaffected bnAb mutations, which occur in the early stages and give antibodies the flexibility to adapt to changes in the structure of ...

18 février 2019, 08:18

296

Cannabis smoking is an independent risk factor for lung disease in people with HIV

Cannabis smoking is an independent risk factor for lung disease in people with HIV

According to a study by a group of scientists from the United States, frequent smoking of cannabis is a risk factor for lung disease in men living with HIV. It increases the likelihood of disease, especially in cases where there is an infectious cause, and does not depend ...

17 février 2019, 08:10

291

EMA approved two new doravirin-based ARV drugs

EMA approved two new doravirin-based ARV drugs

The European Medicines Agency (EMA) has approved the use of drugs for the treatment of HIV Delstrigo and Pifeltro. As previously reported, FDA granted permission for their marketing in the United States at the end of August last year.

16 février 2019, 14:49

375

First evidence of the presence of HIV reservoirs in macrophages

First evidence of the presence of HIV reservoirs in macrophages

Scientists from France recently discovered that macrophages located in the tissue of the urethra may play a much more significant role in the work of HIV cell reservoirs, and that the number of these immune cells is surprisingly large. The results were published last week ...

14 février 2019, 15:26

420

Accounting for HIV and rectal gonorrhea can help make PrEP more effective

Accounting for HIV and rectal gonorrhea can help make PrEP more effective

The results of a study conducted by a group of scientists from the United States showed a correlation between the frequency of rectal gonorrhea and HIV infection among men who have sex with men who do not use pre-exposure prophylaxis (PrEP). According to the researchers, ...

11 février 2019, 15:18

376

In India for the first time disputed patent for bedaquiline

In India for the first time disputed patent for bedaquiline

On February 7 two activists - Nandita Venkatesan (Mumbai, India) and Fumeza Tisile (Khaelitsha, South Africa) - applied to the Indian patent office with a request to revoke Johnson & Johnson's drug for the treatment of drug-resistant tuberculosis (TB) bedaquilines. The statement ...

1 2 3...89